0001209191-17-039027.txt : 20170609 0001209191-17-039027.hdr.sgml : 20170609 20170609215554 ACCESSION NUMBER: 0001209191-17-039027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170609 FILED AS OF DATE: 20170609 DATE AS OF CHANGE: 20170609 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eliseev Alexey CENTRAL INDEX KEY: 0001694380 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 17904241 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-09 0 0001533040 RXi Pharmaceuticals Corp RXII 0001694380 Eliseev Alexey C/O 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 0 1 0 0 Chief Business Officer Common stock, $0.0001 par value 2017-06-09 4 C 0 332499 A 1150312 D Series C Convertible Preferred Stock, $0.0001 par value 2017-06-09 4 C 0 332499 0.00 D Common stock 332499 0 D The Series C Convertible Preferred Stock automatically converted into common stock upon approval by the Company's stockholders in accordance with the stockholder approval requirements of Nasdaq Marketplace Rule 5635 without payment of consideration. The Series C Convertible Preferred Stock have no expiration. Caitlin Kontulis, attorney-in-fact 2017-06-09